More on MRNA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $62.96 |
|
|||
| Open | $116.02 | ||||
| 52 Wk High | $0.52 | ||||
| 52 Wk Low | $0.08 | ||||
| Day High | $176.66 | ||||
| Day Low | $114.46 | ||||
| P/E | N/A | ||||
| EPS | $-3.80 | ||||
| Volume | 191,112,703 | ||||
- Moderna (MRNA) PT Raised to $89 at Morgan Stanley
- Morgan Stanley Upgrades Merck (MRK) to Overweight
- Active options: MRNA AMD AVGO PLTR GOOGL NFLX PFE SOFI NBIS COIN
- BofA Securities Upgrades Moderna (MRNA) to Neutral
- Moderna short sellers face $4.8 billion loss amid record stock jump
- Moderna (MRNA) call put ratio 1 calls to 1.9 puts after INTerpath-001 trial results
- Brookline Capital Markets Reiterates Buy Rating on Moderna (MRNA) Following Positive Intismeran Data
- Stocks expected to have increasing option volume: MRNA RGEN DHR TMO MRVI SKHY
- Moderna (MRNA) call put ratio 2.1 calls to 1 put into INTerpath-001 trial results
- William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
Entities mentioned with MRNA
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Options | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
